Search by Drug Name or NDC

    NDC 59779-0508-14 Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1 Details

    Fexofenadine HCl and Pseudoephedrine HCI 60; 120 mg/1; mg/1

    Fexofenadine HCl and Pseudoephedrine HCI is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 59779-0508
    Product ID 59779-508_aac03106-806f-bc8c-056c-bed65497dd54
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name Fexofenadine HCl and Pseudoephedrine HCI
    Proprietary Name Suffix n/a
    Non-Proprietary Name Fexofenadine HCl and Pseudoephedrine HCI
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 60; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name CVS Pharmacy
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076667
    Listing Certified Through 2024-12-31

    Package

    NDC 59779-0508-14 (59779050814)

    NDC Package Code 59779-508-14
    Billing NDC 59779050814
    Package 4 BLISTER PACK in 1 CARTON (59779-508-14) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2014-11-19
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 3e295047-1a46-a0d8-2e3f-ec4086f5aedb Details

    Revised: 8/2015